Ignite Creation Date:
2025-12-24 @ 10:02 PM
Ignite Modification Date:
2025-12-31 @ 9:04 AM
Study NCT ID:
NCT01033032
Status:
COMPLETED
Last Update Posted:
2022-05-03
First Post:
2009-12-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer
Sponsor:
SCRI Development Innovations, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-12
Start Date Type:
None
Primary Completion Date:
2013-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-10
Completion Date Type:
ACTUAL
First Submit Date:
2009-12-15
First Submit QC Date:
None
Study First Post Date:
2009-12-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-11-21
Results First Submit QC Date:
None
Results First Post Date:
2015-01-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-05
Last Update Post Date:
2022-05-03
Last Update Post Date Type:
ACTUAL